Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage
Our findings suggest that T3 may be a promising intervention for ischemic stroke in the acute phase.
Authors
- Christoph Kleinschnitz (ORCID: https://orcid.org/0000-0002-1650-8875)
- Steffen Haupeltshofer (ORCID: https://orcid.org/0000-0002-7002-9760)
- Friederike Langhauser
- Tim Hagenacker (ORCID: https://orcid.org/0000-0002-3631-3450)
- Markus Leo (ORCID: https://orcid.org/0000-0002-3449-9829)
- Fabian Szepanowski (ORCID: https://orcid.org/0000-0003-3071-4269)
- Linda-Isabell Schmitt (ORCID: https://orcid.org/0000-0003-2506-1080)
- Heike Heuer (ORCID: https://orcid.org/0000-0001-7094-6959)
- Steffen Mayerl (ORCID: https://orcid.org/0000-0002-6072-142X)
- Daniel Ullrich (ORCID: https://orcid.org/0009-0004-6337-6643)
- Dagmar Führer
- Markus Schwaninger
Institutions
- Essen University Hospital (DE)
- University of Duisburg-Essen (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- European Thyroid Journal
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1530/etj-24-0143
- Citations
- 3
- Primary Topic
- Nitric Oxide and Endothelin Effects
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- Deutsche Forschungsgemeinschaft